Not exactly fake diamonds as they are chemically identical.
Currently most of Lucapas production falls into the range that can be man made for a fraction of the cost (the 5ct stone pictured would have come from a +10ct rough, there is evidence that smaller diamonds pricing has already been impacted. DeBeers got into manufacturing these diamonds as they see the risk that new generations of diamond buyers may not care where the stone is from or more concerned, worried about environmental issues or ethical diamond issues. It will all come down to a marketing war to see if these stones are just niche or something more.
- Forums
- ASX - By Stock
- LOM
- diamond news
diamond news, page-3879
-
- There are more pages in this discussion • 1,895 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
Add LOM (ASX) to my watchlist
|
|||||
Last
6.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.43M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15800 | 6.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 31257 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15800 | 0.063 |
2 | 84801 | 0.061 |
1 | 326778 | 0.060 |
1 | 431000 | 0.059 |
1 | 17240 | 0.058 |
Price($) | Vol. | No. |
---|---|---|
0.067 | 31257 | 1 |
0.068 | 150000 | 1 |
0.069 | 42000 | 1 |
0.070 | 92518 | 2 |
0.073 | 10000 | 1 |
Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
LOM (ASX) Chart |
Day chart unavailable